FDA outlines for the House Energy and Commerce Committee its staffing levels of Port of Entry special agents tasked with stopping the flow of illicit ...
FDA says it will pull two proposed regulations that need further work if they are to be finalized.
The DC Circuit Appeals Court says FDA did not act arbitrarily or capriciously in determining that there is no meaningful difference between Rx and OTC...
Federal Register notice: FDA seeks comments on an information collection extension entitled Bar Code Label Requirement for Human Drug and Biological P...
FDA clears an EliTechGroup 510(k) for its HSV 1&2 ELITe MGB Real-Time PCR assay with the ELITe InGenius sample-to-result instrument.
FDA clears a Stimwave Technologies 510(k) for the WaveCrest Mobile iOS Platform patient controllers for opioid-free pain management.
Former FDAer Peter Pitts praises agency efforts to speed approval of generic and branded drugs.
Federal Register notice: FDA announces a 12/4-5 meeting of the Science Advisory Board to the National Center for Toxicological Research.